Cat. No. 0352
Biological ActivityStructural analog of acetylcholine that acts as a nicotinic agonist (Ki = 29.9 nM at α4β2). Upregulates the number of α4β2 binding sites in M10 cells in vitro by 440%.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Warpman et al (1998) Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells. J.Neurochem. 70 2028. PMID: 9572289.
Spivak et al (1988) Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol.Pharmacol. 36 177. PMID: 2747625.
Spivak et al (1986) Structural and electronic requirements for potent agonists at a nicotinic receptor. Eur.J.Pharmacol. 120 127. PMID: 3485051.
If you know of a relevant reference for 4-Acetyl-1,1-dimethylpiperazinium iodide please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses 4-Acetyl-1,1-dimethylpiperazinium iodide from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: 4-Acetyl-1,1-dimethylpiperazinium iodide, supplier, Nicotinic, agonists, Acetylcholine, Receptors, Non-Selective, Subtypes, nAChR, Acetyldimethylpiperazinium, Tocris Bioscience, Nicotinic Receptor (Non-selective) Agonist products
Find multiple products by catalog number
New Products in this Area
Potent positive allosteric modulator of α4β2 nAChRs; also inhibitor of (α4)2(β2)3, muscle-type and Torpedo nAChRs
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.